Medindia

X

Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership

Wednesday, July 21, 2010 Corporate News J E 4
Advertisement


NORTH ATTLEBORO, Mass., July 20 Medical Device Consultants, Inc. (MDCI), a full-service regulatory consulting and contract research organization (CRO) serving the medical device and diagnostics industry, today announced a strategic partnership with Clinical Development & Support Services Ltd (CDSS), a clinical services and CRO based in Cheshire, England. This relationship will allow clients access to the best of both organizations' core strengths and geographical expertise. The service expansion will be accomplished through mutual referrals, coordinated sales, marketing, and presentation activities.

Leslie Rose, Director of Clinical Services at MDCI said, "Our primary aim is to fully support clients as they design and conduct medical device and IVD clinical trials both in the US and Europe. The CDSS network of employee and contract clinical research professionals in the UK and across Europe complements MDCI's full service CRO activities. This collaboration of two former competitors combines our strengths to provide broader and deeper clinical and regulatory solutions for all of our medical device clients."

John Illingworth, Manager Director at CDSS said, "We recognize that our clients need to ensure their clinical research plans meet International regulatory requirements especially in the US and Europe. MDCI's extensive regulatory expertise and network of clinical research professionals in the US makes our alliance a perfect match to achieve this. The blend of both CDSS' and MDCI's skills and infrastructure will allow us to provide all the benefits of working with a large, multinational CRO, whilst retaining the personal, tailored service that both companies pride themselves on."

About MDCI

MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products. Clients trust MDCI to deliver customized strategic guidance and creative "hands-on" solutions to address their unique regulatory, clinical trial, and quality assurance challenges at every stage of the product lifecycle. MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally. By leveraging MDCI's comprehensive knowledge of FDA and international regulations, clients capture and grow market share, increase productivity, and stay competitive in an increasingly complex global marketplace. MDCI has offices in Massachusetts and California. Additional information is available at www.mdci.com.

About CDSS

CDSS has over 30 years experience in providing a wide range of clinical development services to medical device, pharmaceutical and biotechnology companies within the healthcare industry, specialising in Phase I to Phase IV clinical trials and in the provision of monitoring and contract research nursing services. CDSS is the UK's leading independent research nurse provider. Having worked with clients in the UK, Europe and the US, ranging from small start-up companies to large multinational corporations and the National Health Service (NHS), CDSS recognises the individual requirements of clients and provides a service tailored to individual needs. By working closely with the British Consulate across the US, CDSS can help to provide information on and access to any R&D grants, funding or tax credits, which may be available. CDSS has offices in the North of England and Massachusetts, USA. Additional information is available at www.cdssltd.com.

SOURCE Medical Device Consultants, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Beike Biotechnology Opens First Chinese Rehabilita...
S
PharmAthene Announces $3.9 Million Registered Dire...